Intended for healthcare professionals

CCBYNC Open access

Rapid response to:

Research

Anticholinergic drugs and risk of dementia: case-control study

BMJ 2018; 361 doi: https://doi.org/10.1136/bmj.k1315 (Published 25 April 2018) Cite this as: BMJ 2018;361:k1315

Rapid Response:

Re: Anticholinergic drugs and risk of dementia: case-control study

Before we wholeheartedly shun anticholinergics in the elderly we must consider-- are we going to treat urinary incontinence, Parkinson's disease, seizure disorder, and depression? If so, with what? Likewise, aren't patients with each of these diseases more likely to have dementia than those without them? If patients need these medications should we provide pilocarpine or bethanechol simultaneously?

Competing interests: No competing interests

29 April 2018
Jeffrey M. Bloom
Internist
jeffrey M. Bloom, M.D., Inc.
Jeffrey M. Bloom, M.D., Inc.1318 Johnson Ave.San Luis Obispo, CA 93401